For people with Parkinson's disease, higher physical activity may protect two things at once: mobility and mind. A study published October 7 in the journal Neurology found that patients with greater activity levels showed slower worsening of movement symptoms and slower declines in thinking and memory. Study author Dong-Woo Ryu of the University of Cincinnati in Ohio said previous research had linked activity to movement symptoms, but the new work suggests "dual benefits" — associations on both the motor and cognitive tracks.
The study followed 294 people with mild-to-moderate Parkinson's, average age 66, for up to seven years. Participants reported weekly activity across work, home, and hobbies via questionnaire. Moderate activity included brisk walking, doubles tennis, light swimming, and household tasks like washing windows, vacuuming, or mowing the lawn. Vigorous activity included jogging, fast bicycling, team sports, singles tennis, shoveling, and carrying heavy loads.
Researchers split participants into three groups by total weekly activity: low (up to 4 hours), medium (4 to 8 hours), and high (more than 8 hours). Annual testing showed clear separation. On a 0–30 cognitive scale, the low group declined an average of 0.478 points per year, the medium group 0.090, and the high group just 0.007 — essentially flat. On a 0–132 motor symptom scale (average 23 at study start, higher meaning worse), the low group worsened by 0.143 points per year, while the medium group improved by 0.225 and the high group by 0.783.
After adjusting for age, sex, and disease duration, the high-activity group showed slower cognitive decline and slower motor worsening than the low group. All three activity measures — total time, total volume, and vigorous time — pointed the same way.
Ryu himself cooled the takeaway. He said the potential benefits may depend on "how long they stay active and whether they continue exercising over time," and that the between-group differences were small, possibly becoming more meaningful over longer periods. Because participants generally had good cognition at the start, he urged cautious interpretation and more research.
The limitations are plain: activity was self-reported and may be inaccurate; and as an observational study, it shows association only. It cannot prove that exercise slows progression — it is equally possible that people with milder disease simply move more.
The finding joins a lengthening chain. In 2022, Kazuto Tsukita's team at Kyoto University reported in Neurology on 237 early-stage patients followed for six years: those keeping up at least four hours a week of moderate-to-vigorous exercise showed slower decline in balance and walking five years later — and what mattered was maintaining activity over time, not how active they were at diagnosis. Tsukita noted that drugs relieve symptoms but have not been shown to slow progression, while exercise is "low cost and has few side effects."
A separate trial at the University of Colorado found high-intensity exercise (80–85% of maximum heart rate) held early patients' symptom scores steady over six months while non-exercisers worsened by 3 points — a difference the researchers called clinically meaningful for quality of life.
Parkinson's is a progressive brain disorder; movement and cognitive problems gradually erode independence. No drug has been proven to slow its course. If exercise can drag on both decline curves at once, it is one of the few interventions patients control themselves.
For clinicians, the study supports putting an "exercise prescription" higher on the agenda — not vague advice to move more, but help finding an intensity and rhythm the patient can sustain for years. Brisk walking, swimming, gardening, and housework all count; persistence is the point. For families, building a regular activity routine with the patient may beat buying supplements.
The honest next step is randomized controlled trials: assign patients to different exercise regimens and see whose decline is slower years later — the only route toward causation. Open questions include dose (is eight hours a week a threshold, or is more better?) and safety (is vigorous exercise safe for everyone?).
Until then, the safest reading: exercise will not cure Parkinson's, but the evidence that it may be one of the cheapest ways to slow decline keeps piling up. Moving beats sitting — true for a 66-year-old patient, and for everyone else too.